ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The T-cell-specific cell-surface receptors CD28 and CTLA-4 are important regulators of the immune system. CD28 potently enhances those T-cell functions that are essential for an effective antigen-specific immune response, and the homologous CTLA-4 counterbalances the CD28-mediated signals and thus prevents an otherwise fatal overstimulation of the lymphoid system. Here we report the identification of a third member of this family of molecules, inducible co-stimulator (ICOS), which is a homodimeric protein of relative molecular mass 55,000-60,000 (M(r) 55K-60K). Matching CD28 in potency, ICOS enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, upregulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B cells. Unlike the constitutively expressed CD28, ICOS has to be de novo induced on the T-cell surface, does not upregulate the production of interleukin-2, but superinduces the synthesis of interleukin-10, a B-cell-differentiation factor. In vivo, ICOS is highly expressed on tonsillar T cells, which are closely associated with B cells in the apical light zone of germinal centres, the site of terminal B-cell maturation. Our results indicate that ICOS is another major regulator of the adaptive immune system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune co-stimulator (ICOS) is a co-stimulatory molecule expressed on T cells, which enhances function and expansion of CD8+ T cells and Tregs (Fu et al., 2011; Hutloff et al., 1999; Liakou et al., 2008).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Hutloff et al., 1999
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.381 · Cited by 2,254
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
MacLennan, I. C. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.117 · Cited by 1,729
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239 · cited 1×
“Protein material from five gels was pooled, in situ -digested with trypsi”
Method
Cited by
Items 301–400 of 1,001
Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
Lohmueller, J. J., & Finn, O. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.008 · Cited by 101
“Co-signaling domains to date include CD28, 4-1BB, ICOS, DAP10 and OX40 (Altvater, Pscherer, Juergens, & Rossig, 2005; Guedan et al., 2014; Maher et al., 2002; Zhong et al., 2010).”
BackgroundInfluentialPlatt, A. M., Gibson, V. B., Patakas, A., Benson, R. A., Nadler, S. G., Brewer, J. M., McInnes, I. B., & Garside, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001311 · Cited by 96
Costimulatory receptors in jawed vertebrates: Conserved CD28, odd CTLA4 and multiple BTLAs
BERNARD, D., Hansen, J. A., DuPasquier, L., Lefranc, M., Benmansour, A., & Boudinot, P. (2006) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2006.06.003 · Cited by 100
Cytokine memory of T helper lymphocytes
Löhning, M., Richter, A., & Radbruch, A. (2002) · Advances in immunology · doi:10.1016/s0065-2776(02)80014-1 · Cited by 110
The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology
Mohseni, Y. R., Tung, S. L., Dudreuilh, C., Lechler, R. I., Fruhwirth, G. O., & Lombardi, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01608 · Cited by 98
“Tregs suppress the immune system by different mechanisms including contact-dependent mechanisms, through CTLA-4 engagement for example, and contact-independent, such as the release of cytokines e.g., IL-35 or IL-10 [reviewed in (9)].”
BackgroundBUGEON, L., & DALLMAN, M. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.supplement_3.15tac5 · Cited by 94
Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes
Edner, N. M., Heuts, F., Thomas, N., Wang, C. J., Petersone, L., Kenefeck, R., Kogimtzis, A., Ovcinnikovs, V., Ross, E. M., Ntavli, E., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0744-z · Cited by 90
Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy
Amatore, F., Gorvel, L., & Olive, D. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1444753 · Cited by 98
Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy
Horton, J. D., Knochelmann, H. M., Day, T. A., Paulos, C. M., & Neskey, D. M. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.02.007 · Cited by 103
“Finally, inducible T cell co-stimulator (ICOS) is expressed on activated T cells [71], promotes a Th2 response, and is enriched on the surface of CD4+ T cells in HSNCC [66].”
BackgroundCommon variable immunodeficiency: the immune system in chaos
Bayry, J., Hermine, O., Webster, D., Lévy, Y., & Kaveri, S. V. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.005 · Cited by 94
The complex role of B7 molecules in tumor immunology
Seliger, B., Marincola, F. M., Ferrone, S., & Abken, H. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.010 · Cited by 91
Molecular mechanisms of T‐cell tolerance
Nurieva, R. I., Liu, X., & Dong, C. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01012.x · Cited by 89
Dendritic cells in asthma: a function beyond sensitization
van Rijt, L. S., & Lambrecht, B. N. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02321.x · Cited by 93
Death-receptor contribution to the germinal-center reaction
van Eijk, M., Defrance, T., Hennino, A., & de Groot, C. H. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02086-5 · Cited by 108
Role of T cell costimulation in anti-viral immunity
Bertram, E. M., Dawicki, W., & Watts, T. H. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.02.006 · Cited by 107
T and B‐cell signaling in activated PI3K delta syndrome: From immunodeficiency to autoimmunity
Preite, S., Gómez‐Rodríguez, J., Cannons, J. L., & Schwartzberg, P. L. (2019) · Immunological Reviews · doi:10.1111/imr.12790 · Cited by 91
Wahl, P. R., Schoop, R., Bilic, G., Neuweiler, J., Hir, M. L., Yoshinaga, S. K., & Wuthrich, R. P. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000017901.77985f · Cited by 96
Melero, I., Tanos, T., Bustamante, M., Sanmamed, M. F., Calvo, E., Moreno, I., Moreno, V., Hernández‐Guerrero, T., Martinez‐García, M., Rodríguez‐Vida, A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abp9229 · Cited by 91
“A. Hutloff, A. M. Dittrich, K. C. Beier, B. Eljaschewitsch, R. Kraft, I. Anagnostopoulos, R. A. Kroczek, ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.”
BackgroundCostimulatory pathways in transplantation
Pilat, N., Sayegh, M. H., & Wekerle, T. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.04.002 · Cited by 93
ICOS/ICOSL Interaction Is Required for CD4+ Invariant NKT Cell Function and Homeostatic Survival
Akbari, O., Stock, P., Meyer, E. H., Freeman, G. J., Sharpe, A. H., Umetsu, D. T., & DeKruyff, R. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5448 · Cited by 89
T‐follicular helper cell differentiation and the co‐option of this pathway by non‐helper cells
Linterman, M. A., Liston, A., & Vinuesa, C. G. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01121.x · Cited by 94
Fukuda, R.-I., Hayashi, A., Utsunomiya, A., Nukada, Y., Fukui, R., Itoh, K., Tezuka, K., Ohashi, K., Mizuno, K., Sakamoto, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507184102 · Cited by 88
Bacchelli, C., Buckridge, S., Thrasher, A. J., & Gaspar, H. B. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03461.x · Cited by 88
T cell immune abnormalities in immune thrombocytopenia
Ji, X., Zhang, L., Peng, J., & Hou, M. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0072-6 · Cited by 88
Petroff, M. G., Kharatyan, E., Torry, D. S., & Holets, L. M. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62990-2 · Cited by 90
Role of ICOS versus CD28 in antiviral immunity
Bertram, E. M., Tafuri, A., Shahinian, A., Chan, V. S. F., Hunziker, L., Recher, M., Ohashi, P. S., Mak, T. W., & Watts, T. H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200212)32:12<3376::aid-immu3376>3.0.co;2-y · Cited by 87
Regulatory T cells and T helper 17 cells in viral infection
Wan, Z., Zhou, Z., Liu, Y., Lai, Y., Luo, Y., Peng, X., & Zou, W. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12873 · Cited by 96
Ménétrier‐Caux, C., Curiel, T. J., Faget, J., Manuel, M., Caux, C., & Zou, W. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0208-y · Cited by 95
Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease
Ban, Y., Davies, T. F., Greenberg, D. A., Kissin, A. G., Marder, B. A., Murphy, B. T., Concepcion, E. S., Villanueva, R., Barbesino, G., Ling, V., et al. (2003) · Genes and Immunity · doi:10.1038/sj.gene.6364018 · Cited by 86
Liang, L., Porter, E. M., & Sha, W. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020298 · Cited by 84
Lee, H.-J., Kim, S.-N., Jeon, M., Yi, T., & Song, S. U. (2017) · Scientific Reports · doi:10.1038/srep44486 · Cited by 89
Targeting extracellular matrix stiffness for cancer therapy
Feng, X., Cao, F., Wu, X., Xie, W., Wang, P., & Jiang, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1467602 · Cited by 87
T-cell activation: a multidimensional signaling network
Tseng, S.-Y., & Dustin, M. L. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00370-8 · Cited by 97
Yap, T. A., Gainor, J. F., Callahan, M. K., Falchook, G. S., Pachynski, R. K., LoRusso, P. M., Kummar, S., Gibney, G. T., Burris, H. A., Tykodi, S. S., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4256 · Cited by 85
Common Variable Immunodeficiency: An Update on Etiology and Management
Yong, P. F. K., Tarzi, M. D., Chua, I. C., Grimbacher, B., & Chee, R. (2008) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2008.01.001 · Cited by 83
Arimura, Y., Kato, H., Dianzani, U., Okamoto, T., Kamekura, S., Buonfiglio, D., Miyoshi‐Akiyama, T., Uchiyama, T., & Yagi, J. (2002) · International Immunology · doi:10.1093/intimm/dxf022 · Cited by 83
Cook, A., McDonnell, A. M., Lake, R., & Nowak, A. K. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1066062 · Cited by 88
Primary B-cell immunodeficiencies
Smith, T., & Cunningham‐Rundles, C. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.10.015 · Cited by 94
“ICOS, a member of the CD28 and CTLA4 (cytotoxic T-lymphocyte associated protein 4, OMIM: 123890) family of proteins, is required for interaction with its cognate receptor on antigen presenting cells (B7) and is required for germinal center formation and terminal B-cell differentiation [51].”
BackgroundWong, S.-C., Oh, E., Ng, C.-H., & Lam, K.-P. (2003) · Blood · doi:10.1182/blood-2002-08-2416 · Cited by 79
T Cells: Soldiers and Spies—The Surveillance and Control of Effector T Cells by Regulatory T Cells
Hall, B. M. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06620714 · Cited by 75
The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon γ production
Howie, D., Okamoto, S., Rietdijk, S. T., Clarke, K., Wang, N., Gullo, C. A., Bruggeman, J. P., Manning, S., Coyle, A. J., Greenfield, E. A., et al. (2002) · Blood · doi:10.1182/blood-2002-02-0445 · Cited by 91
Borel, C., Jung, A. C., & Burgy, M. (2020) · Cancers · doi:10.3390/cancers12092691 · Cited by 83
“ICOS is highly up-regulated upon T cells receptor stimulation [44] and is expressed on tumor infiltrating lymphocytes in many tumors [45].”
BackgroundLian, J., Liang, Y., Zhang, H., Lan, M., Ye, Z., Lin, B., Qiu, X., & Zeng, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912279 · Cited by 84
Ihara, K., Ahmed, S., Nakao, F., Kinukawa, N., Kuromaru, R., Matsuura, N., Iwata, I., Nagafuchi, S., Kohno, H., Miyako, K., et al. (2001) · Immunogenetics · doi:10.1007/s002510100351 · Cited by 90
B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4
Mandelbrot, D. A., Oosterwegel, M. A., Shimizu, K., Yamada, A., Freeman, G. J., Mitchell, R. N., Sayegh, M. H., & Sharpe, A. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11710 · Cited by 84
Dendritic Cells: A Critical Player in Cancer Therapy?
Palucka, A. K., Ueno, H., Fay, J. W., & Banchereau, J. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31818403bc · Cited by 87
Giambartolomei, G. H., Delpino, M. V., Cahanovich, M. E., Wallach, J. C., Baldi, P. C., Velikovsky, C. A., & Fossati, C. A. (2002) · The Journal of Infectious Diseases · doi:10.1086/341449 · Cited by 89
ICOS costimulation: it's not just for TH2 cells anymore
Sperling, A. I., & Bluestone, J. A. (2001) · Nature Immunology · doi:10.1038/89709 · Cited by 80
Kosuge, H., Suzuki, J., Gotoh, R., Koga, N., Ito, H., Isobe, M., Inobe, M., & Uede, T. (2003) · Transplantation · doi:10.1097/01.tp.0000061601.26325.82 · Cited by 80
ICOS Ligand Costimulation Is Required for T-Cell Encephalitogenicity
Sporici, R. A., Beswick, R. L., von Allmen, C., Rumbley, C. A., Hayden-Ledbetter, M. S., Ledbetter, J. A., & Perrin, P. J. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5074 · Cited by 80
Kusuda, T., Uchida, K., Miyoshi, H., Koyabu, M., Satoi, S., Takaoka, M., Shikata, N., Uemura, Y., & Okazaki, K. (2011) · Pancreas · doi:10.1097/mpa.0b013e31821fc796 · Cited by 79
The expression, function, and clinical relevance of B7 family members in cancer
Seliger, B., & Quandt, D. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1293-6 · Cited by 85
Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells
Bourque, J., & Hawiger, D. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026790 · Cited by 82
Common Variable Immunodeficiency: More Pathways than Roads to Rome
Peng, X. P., Caballero-Oteyza, A., & Grimbacher, B. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-024229 · Cited by 82
Generation and Characterization of B7-H4/B7S1/B7x-Deficient Mice
Suh, W.-K., Wang, S., Duncan, G. S., Miyazaki, Y., Cates, E., Walker, T., Gajewska, B. U., Deenick, E., Dawicki, W., Okada, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00755-06 · Cited by 77
Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy
Jeong, S., & Park, S. (2020) · Immune Network · doi:10.4110/in.2020.20.e3 · Cited by 84
Insights into the Role of Follicular Helper T Cells in Autoimmunity
Park, H.-J., Kim, D.-H., Lim, S., Kim, W., Youn, J., Choi, Y.-S., & Choi, J. (2014) · Immune Network · doi:10.4110/in.2014.14.1.21 · Cited by 80
Löfgren's Syndrome: Diagnosis, Management, and Disease Pathogenesis
Kaiser, Y., van Moorsel, C. H. M., Grünewald, J., & Karakaya, B. (2017) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1602380 · Cited by 84
Co-signal Molecules in T-Cell Activation: Historical Overview and Perspective
Azuma, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_1 · Cited by 84
Ogasawara, K., Yoshinaga, S. K., & Lanier, L. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3676 · Cited by 87
Essential Role of NF-κB-Inducing Kinase in T Cell Activation Through the TCR/CD3 Pathway
Matsumoto, M., Yamada, T., Yoshinaga, S. K., Boone, T., Horan, T., Fujita, S., Li, Y., & Mitani, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1151 · Cited by 77
EphB6 crosslinking results in costimulation of T cells
Luo, H., Yu, G., Wu, Y., & Wu, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15883 · Cited by 77
Zhao, M., Svensson, M. N. D., Venken, K., Chawla, A., Liang, S. Y., Engel, I., Mydel, P. M., Day, J., Elewaut, D. S., Bottini, N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05095-7 · Cited by 76
T Cell Signal Transduction and the Role of CD7 in Costimulation
Stillwell, R., & Bierer, B. E. (2001) · Immunologic Research · doi:10.1385/ir:24:1:31 · Cited by 84
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Ascierto, P. A., Marincola, F. M., & Ribas, A. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-196 · Cited by 76
The ICOS Molecule Plays a Crucial Role in the Development of Mucosal Tolerance
Miyamoto, K., Kingsley, C. I., Zhang, X., Jabs, C., Izikson, L., Sobel, R. A., Weiner, H. L., Kuchroo, V. K., & Sharpe, A. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7341 · Cited by 76
Silva, D. M. D., Enserro, D. M., Mayadev, J., Skeate, J. G., Matsuo, K., Pham, H. Q., Lankes, H. A., Moxley, K. M., Ghamande, S. A., Lin, Y. G., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0776 · Cited by 79
Critical role of CD81 in cognate T–B cell interactions leading to Th2 responses
Deng, J., DeKruyff, R. H., Freeman, G. J., Umetsu, D. T., & Levy, S. (2002) · International Immunology · doi:10.1093/intimm/14.5.513 · Cited by 75
Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation
Riffo‐Vasquez, Y., & Spina, D. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00217-6 · Cited by 85
Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen
Kohyama, M., Sugahara, D., Sugiyama, S., Yagita, H., Okumura, K., & Hozumi, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400214101 · Cited by 74
Detection of Immune Checkpoint Receptors – A Current Challenge in Clinical Flow Cytometry
Shibru, B., Fey, K., Fricke, S., Blaudszun, A., Fürst, F., Weise, M., Seiffert, S., Weyh, M. K., Koehl, U., Sack, U., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.694055 · Cited by 84
“Blockade of ICOS-L disrupts binding to ICOS (CD278), which is an activating co-stimulatory checkpoint receptor up-regulated upon early T-cell activation (89, 91).”
BackgroundMaintenance of Immune Homeostasis through ILC/T Cell Interactions
von Burg, N., Turchinovich, G., & Finke, D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00416 · Cited by 78
Microanatomical localization of PD-1 in human tonsils
Iwai, Y., Okazaki, T., Nishimura, H., Koyanagi, A., Yagita∥, H., & Honjo, T. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00088-3 · Cited by 77
T lymphocyte co-signaling pathways of the B7-CD28 family.
Wang, S., & Chen, L. (2004) · PubMed · Cited by 74
CD28 and ICOS: Similar or separate costimulators of T cells?
van Berkel, M. E. A. T., & Oosterwegel, M. A. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.02.007 · Cited by 84
Costimulatory wars: the tumor menace
Hurwitz, A. A., Kwon, E. D., & van Elsas, A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00147-3 · Cited by 80
Cytokines and T cells in host defense
Hunter, C. A., & Reiner, S. L. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00110-2 · Cited by 85
Massarelli, E., Lam, V. K. L., Parra, E. R., Rodriguez‐Canales, J., Behrens, C., Diao, L., Wang, J., Blando, J. M., Byers, L. A., Yanamandra, N., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0827-2 · Cited by 78
Magee, C. N., Boenisch, O., & Najafian, N. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04180.x · Cited by 86
14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency
Schepp, J., Chou, J. S., Skrabl‐Baumgartner, A., Arkwright, P. D., Engelhardt, K. R., Hambleton, S., Morio, T., Röther, E., Warnatz, K., Geha, R. S., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00964 · Cited by 72
The genomic architecture of mastitis resistance in dairy sheep
Banos, G., Bramis, G., Bush, S. J., Clark, E. L., McCulloch, M., Smith, J., Schulze, G., Arsenos, G. I., Hume, D. A., & Psifidi, A. (2017) · BMC Genomics · doi:10.1186/s12864-017-3982-1 · Cited by 81
Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
Chrétien, S., Zerdes, I., Bergh, J. C. S., Matikas, A., & Foukakis, T. (2019) · Cancers · doi:10.3390/cancers11050628 · Cited by 78
“Inducible T cell co-stimulator (ICOS) is a specific T-cell molecule of the B7-binding CD28 family, expressed on activated T-cells after TCR engagement and enhanced by CD28 co-stimulation [136,137].”
BackgroundShirai, Y., Nakanishi, Y., Suzuki, A., Konaka, H., Nishikawa, R., Sonehara, K., Namba, S., Tanaka, H., Masuda, T., Yaga, M., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2022-222460 · Cited by 74
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40–Mediated Tumor Rejection
Metzger, T. C., Long, H., Potluri, S., Pertel, T., Bailey-Bucktrout, S. L., Lin, J. C.-Y., Fu, T., Sharma, P., Allison, J. P., & Feldman, R. M. R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3412 · Cited by 73
Regulation of costimulation in the era of butyrophilins
Arnett, H. A., Escobar, S. M., & Viney, J. L. (2009) · Cytokine · doi:10.1016/j.cyto.2009.03.009 · Cited by 77
Smith, K. M., Brewer, J. M., Webb, P., Coyle, A. J., Gutierrez-Ramos, C., & Garside, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2310 · Cited by 80
Totsuka, T., Kanai∥, T., Iiyama, R., Uraushihara, K., Yamazaki, M., Okamoto, R., Hibi∥, T., Tezuka, K., Azuma, M., Akiba, H., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50050 · Cited by 71
The balance of immune responses: costimulation verse coinhibition
Subudhi, S. K., Alegre, M., & Fu, Y. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0617-1 · Cited by 82
Nuocytes: expanding the innate cell repertoire in type-2 immunity
Barlow, J. L., & McKenzie, A. N. J. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311160 · Cited by 69
PI3Ks in Lymphocyte Signaling and Development
Okkenhaug, K., & Fruman, D. A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_45 · Cited by 70
Reactive metabolites and their role in drug reactions
Naisbitt, D. J., Williams, D. P., Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (2001) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200108000-00007 · Cited by 80
Hedl, M., Lahiri, A., Ning, K., Cho, J. H., & Abraham, C. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.011 · Cited by 75
The role of ICOS in the development of CD4 T cell help and the reactivation of memory T cells
Mahajan, S., Cervera, A. M., MacLeod, M. K. L., Fillatreau, S., Perona‐Wright, G., Meek, S. E., Smith, A., MacDonald, A. S., & Gray, D. (2007) · European Journal of Immunology · doi:10.1002/eji.200636661 · Cited by 70
Nanji, S. A., Hancock, W. W., Anderson, C. C., Adams, A. B., Luo, B., Schur, C. D., Pawlick, R. L., Wang, L., Coyle, A. J., Larsen, C. P., et al. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00384.x · Cited by 74
Schenka, A. A., Gorbachevab, V., Rabantb, M., Fairchild, R. L., & Valujskikh, A. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02460.x · Cited by 72
Specific central nervous system recruitment of HLA‐G+ regulatory T cells in multiple sclerosis
Huang, Y., Zozulya, A. L., Weidenfeller, C., Metz, I., Buck, D., Toyka, K. V., Brück, W., & Wiendl, H. (2009) · Annals of Neurology · doi:10.1002/ana.21705 · Cited by 69
The Role of Costimulatory Molecules in Allergic Disease and Asthma
Lombardi, V., Singh, A. K., & Akbari, O. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000242355 · Cited by 81
“Taken together, these studies suggest that overexpression of CD80 and/or CD86 is correlated with the development of allergic disease and asthma.Within the B7 family, CD28 and inducible costimulator (ICOS) are most homologous with respect to structure and function. Both are type I transmembrane receptors expressed as h…”
BackgroundOgawa, S., Nagamatsu, G., Watanabe, M., Watanabe, S., Hayashi, T., Horita, S., Nitta, K., Nihei, H., Tezuka, K., & Abe, R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5741 · Cited by 72
Suh, W.-K., Tafuri, A., Berg-Brown, N. N., Shahinian, A., Plyte, S., Duncan, G. S., Okada, H., Wakeham, A., Odermatt, B., Ohashi, P. S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5917 · Cited by 68
CD81 and CD28 Costimulate T Cells Through Distinct Pathways
Witherden, D. A., Boismenu, R., & Havran, W. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1902 · Cited by 79
Metadata
- Authors
- Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A.
- Affiliations
- Robert Koch Institute (DE)
- Max Delbrück Center (DE)
- Freie Universität Berlin (DE)
- Corresponding author
- Kroczek, Richard A.
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6716
- Pages
- 263-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1661441964
- Cited by
- 1,482
- References
- 30
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 52 · 2023: 41 · 2022: 66 · 2021: 54 · 2020: 60 · 2019: 53 · 2018: 52 · 2017: 32 · 2016: 44 · 2015: 41 · 2014: 35 · 2013: 53 · 2012: 47
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- ICOS, CD28, CTLA-4, T cell costimulation, T cell proliferation, lymphokine secretion, IL-10, B cell help, germinal center, adaptive immune regulation
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Cell Communication, Cell Line, Cloning, Molecular, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Molecular Sequence Data, T-Lymphocytes, CD28 Antigens, Germinal Center, Mice, Inducible T-Cell Co-Stimulator Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.